NGLY1 deficiency is a rare inherited disorder caused by mutations in the NGLY1 gene encoding N-glycanase 1 that is a hydrolase for N-linked glycosylated proteins. An induced pluripotent stem cell (iPSC) line was generated from the dermal fibroblasts of a 16-year-old patient with homozygous mutation of p.R401X (c.1201 A >T) in the NGLY1 gene. Our iPSC model offers a useful resource to study the disease pathophysiology and to develop therapeutics for treatment of NGLY1 patients.
Resource details
NGLY1 deficiency, also known as NGLY1-related congenital disorder of deglycosylation, is a rare autosomal recessive disorder caused by mutations in the NGLY1 gene which encodes a specialized enzyme called N-glycanase that removes N-linked glycan from glycosylated proteins within the body. Deficiency of this protein can lead to malfunctions of cellular functions and accumulation of misfolded proteins within cells in specific tissues or organs. The symptoms and severity of this disease can dramatically vary among affected individuals, who may have developmental delays, intellectual disability, movement disorders, seizures, liver disease, and alacrima (Enns et al., 2014; Lam et al., 2017; Caglayan et al., 2015) .
In this study, a human dermal fibroblast was derived from a 16-year-old female patient (GM26612, Coriell Institute) with a homozygous nonsense mutation of p.R401X (c.1201A > T) in exon 8 of the NGLY1 gene (3p24.2) (Enns et al., 2014; Need et al., 2012) . The iPSC line, TRNDi010-C, was reprogramed from the fibroblasts using the non-integrating CytoTune-Sendai viral vector kit (A16517, Thermo Fisher Scientific) containing four pluripotency transcription factors, OCT3/4, KLF4, SOX2, and c-MYC (Beers et al., 2015) . Individual colonies were picked, expanded and further analyzed at the cellular and genetic level to confirm successful reprogramming (Table 1 ). The TRNDi010-C iPS cells displayed the standard pluripotent stem cell morphology under phase contrast microscopy and expressed pluripotency markers OCT4, NANOG and SOX2 in the nuclei and SSEA4 and TRA-1-60 on the plasma membrane (Fig. 1A) . The quantitative analysis by flow cytometry revealed 98.36% and 84.09% expression rate of TRA-1-60 and NANOG, respectively (Fig.  1B ). G-banded karyotyping analysis was used to confirm the karyotype, which showed the normal diploid 46, XX, without any detectable abnormalities (Fig. 1C ). The genetic mutation, c.1201A > T (p.R401X), was validated by Sanger sequencing of the PCR product harboring the single nucleotide variant ( Fig. 1D) , consistent with the description of Coriell Institute. After passage 30, the exogenous reprogramming factors were eliminated from TRNDi010-C iPSCs, despite the remaining low level of SeV ( Fig. 1E ). To further test the pluripotency of this iPSC line, teratoma formation experiment was performed. As shown in Fig. 1F , the imaging data identified its ability to generate derivative of three germ layers, ectoderm, mesoderm and endoderm in vivo. Furthermore, this iPSC was negative for mycoplasma contamination ( Supplementary Fig. S1 ). The STR DNA profile of the TRNDi010-C matched with its parental GM26612 fibroblast at all 18 loci (information available with the authors).
Materials and methods

Cell culture and reprogramming
Patient skin fibroblasts were obtained from Coriell Cell Repositories (GM26612), and cultured in DMEM supplemented with 10% fetal bovine serum, 100 units/mL penicillin and 100 μg/mL streptomycin in a humidified incubator with 5% CO 2 at 37 °C. Patient fibroblasts were reprogrammed into iPSCs using the non-integrating Sendai virus technology (Beers et al., 2015) . Human iPSCs were cultured in mTeSR™1 (STEMCELL Technologies) on Matrigel (Corning, 354277)-coated plates at 37 °C in humidified air with 5% CO 2 and 5% 
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Genome analysis
The genome analysis of variants in NGLY1 was conducted through Applied StemCell (Milpitas, California, USA Table 2 ). Cells were then stained with Hoechst 33342 for 15 min and imaged using an INCell Analyzer 2500 imaging system (GE Healthcare) with Cy5, FITC and DAPI filter sets.
Flow cytometry analysis
The iPSCs were dissociated by TrypLE Express enzyme (Thermo Fisher Scientific). After washing once with DPBS, cells were fixed with 4% paraformaldehyde for 10 min and were permeabilized with 0.2% Tween-20 in DPBS for another 10 min at room temperature, followed by staining with fluorophore-conjugated antibodies (Table 2) for 1 h at 4 °C. The cells were then analyzed on a BD AccuriC6 FlowCytometry system (BD Biosciences).
G-banded karyotyping
The G-banded karyotyping analysis was performed by the WiCell Research Institute (Madison, WI) using the iPS cells at passage 6. Twenty randomly selected metaphase cells were selected for the standard cytogenetic analysis.
Short tandem repeat (STR) analysis
The STR analysis of patient fibroblasts and iPSCs was performed by the Johns Hopkins University Genetic Resources Core Facility using the Promega PowerPlex 18D Kit. The ABI Prism® 3730xl Genetic Analyzer was used to electrophorese the PCR products and GeneMapper® v 4.0 software (Applied Biosystems) was used to analyze the data.
Mycoplasma detection
The Lonza MycoAlert kit was used to assess the mycoplasma according to the instructions from the company. B/A ratio > 1.2 indicates the positive sample; 0.9-1.2 indicates the ambiguous result; < 0.9 indicates the negative sample.
Sendai virus detection
Using the RNeasy Plus Mini Kit (Qiagen), the total RNA was extracted. The cDNA was reverse-transcribed from 1 μg RNA by SuperScript™ III First-Strand Synthesis SuperMix (Thermo Fisher Scientific). The Platinum II Hot-Start PCR Master Mix (Thermo Fisher Scientific) was used to amplify the target sequence with a PCR program: 94 °C, 2 min; 30 cycles of 94 °C, 15 s, 60 °C, 15 s, and 68 °C, 15 s on Mastercycler pro S (Eppendorf) with the specific primers ( Table 2 ). The human fibroblasts (GM05659, Coriell Institute) transfected with Sendai virus for 4 days was used as the positive control.
Teratoma formation assay
Patient iPSCs were dissociated with 0.5 mM EDTA in PBS and were resuspended approximately 1 × 10 7 cells in 400 μL culture medium supplied with 25 mM HEPES (pH 7.4) and stored on ice. Then, 50% volume (200 μL) of cold Matrigel (Corning, 354277) was added and mixed with the cells. The mixture was injected subcutaneously into NSG mice (JAX No. 005557) at 150 μL per injection site. Visible tumors were removed 6-8 weeks post-injection and were immediately fixed in 10% Neutral Buffered Formalin. The fixed tumors were embedded in paraffin and stained with hematoxylin and eosin.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Characterization and validation. Table 2 Reagents details. 
